↑: Increased with regard to normal levels; ↓: Decreased with regard to normal levels; CTL: Cytotoxic T lymphocyte; MDS: Myelodysplastic syndrome.

In one approach we are developing techniques to separate out the specific cells that evoke this response, the T lymphocytes, and deliver a stem cell product that is very low in these T cells. These ...

January's FDA oncology approvals offer new treatment options for breast cancer, mantle cell lymphoma, and other malignancies.